Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We would like to congratulate Dr Audrey Gérard on her three-year Biotechnology and Biological Sciences Research Council (BBSRC) New Investigator Award. The award will allow Audrey to examine how the behaviour of killer T cells is coordinated to optimise immunity against pathogens and tumour growth.

Dr Audrey Gérard in her lab at the Kennedy Institute.

Killer CD8 T cells attack infected or mutated cells to protect against pathogens and tumour growth. There are many different CD8 T cell clones in the body – only a fraction of these recognise the same target and the amount of protection offered by each clone varies.

Audrey's group uses state-of-the-art imaging approaches to understand how CD8 T cell clones talk to each other during an immune response. Their work will determine how different clones coordinate their activity to rapidly clear infection and establish long-term immunity, while limiting damage to the body's own tissues. This information may guide the development of better vaccines, such as against influenza infection.

"This award is an amazing opportunity for me to tackle this project, which aims to study how CD8 T cells organise themselves as an ecosystem during healthy responses. I believe it will give a different perspective on our understanding of immune response coordination and regulation", said Dr Gérard.

Director of Research at the Kennedy Institute, Professor Michael Dustin, said: "This award recognises Audrey's fundamental work in immunobiology, laying the foundation for future cures."

Audrey joined the Kennedy Institute in 2016 as a Senior Research Fellow funded by the Kennedy Trust for Rheumatology Research.

Funding

BBSRC logo

 

 

 

Similar stories

Fiona Powrie honoured by British Society for Immunology

Fiona Powrie was one of four researchers from the University of Oxford recognised for their outstanding contributions to immunology with Honorary Lifetime Membership of the British Society for Immunology.

The Kennedy Institute scoops sustainability award

A new roof extension was awarded the 2021 Green Award for Sustainability by the Oxford Preservation Trust alongside a Certificate in the New Building category.

Vaccination safety: generating accurate evidence is the clearest path to creating public trust

A new study shows that a vaccine surveillance method in observational data may generate high number of false positives

Fiona Powrie appointed new Deputy Chair of Wellcome’s Board of Governors

Fiona Powrie, Director of the Kennedy Institute of Rheumatology at the University of Oxford has been selected as the next Deputy Chair of Wellcome’s Board of Governors.

A drug being trialled to treat cancer, could be the key to reducing gut inflammation

Published in Nature Communications, a new study reveals a new signalling pathway behind macrophage inflammatory activity

Single-cell ancestry vaccine research funded by the Chan Zuckerberg Initiative

The Chan Zuckerberg Initiative (CZI) has provided $2 million in funding to investigate how our ancestry and diversity influence the way that vaccines work in our cells.